Advertisement

Ileal Interposition with Sleeve Gastrectomy for the Treatment of Type 2 Diabetes

  • Aureo L. DePaula
  • Carolina C. L. DePaula
  • Surendra Ugale

Abstract

Type 2 diabetes mellitus (T2DM) and obesity are predicted to be two of the greatest public health problems of the coming decades globally. Worldwide, the prevalence of Diabetes is increasing and vascular complications are the main cause of death. Indeed, during 1988–2000 the annual all-cause mortality rates among T2DM patients were 25.2 per 1000 person-years compared with 9.5 per 1000 person-years in those without diabetes in the US population age 35–74 years. Cardiovascular (CV) disease mortality in this diabetic population was 11.1 per 1000 person-years compared to 3.4 per 1000 person-years in those without diabetes.

Keywords

Ileal Interposition Sleeve gastrectomy Type 2 diabetes mellitus Obesity 

Notes

The authors attest that there is no conflict of interest to disclose related to this book chapter.

References

  1. 1.
    Fox CS, Coady S, Sorlie PD, D’Agostino Sr RB, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation. 2007;115:1544–50.PubMedCrossRefGoogle Scholar
  2. 2.
    Gregg EW, Qiuping G, Cheng YJ, Venkat Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med. 2007;147:149–55.PubMedCrossRefGoogle Scholar
  3. 3.
    Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32.PubMedCrossRefGoogle Scholar
  4. 4.
    Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I. Weight and T2DM after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56.PubMedCrossRefGoogle Scholar
  5. 5.
    Adams T, Gress R, Smith S, Halverson C, Simper S, Rosamond W, LaMonte M, Stroup A, Hunt S. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.PubMedCrossRefGoogle Scholar
  6. 6.
    Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E, Mackey J, Kennedy L, Kashya SR, Kirwan JP, Rogula T, Kroh M, Chand B, Schauer PR. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013;258(4):628–37.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with T2DM mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999;281:2005–12.PubMedCrossRefGoogle Scholar
  8. 8.
    Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335–42.PubMedCrossRefGoogle Scholar
  9. 9.
    Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.PubMedCrossRefGoogle Scholar
  10. 10.
    The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.CrossRefGoogle Scholar
  11. 11.
    The VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.CrossRefGoogle Scholar
  12. 12.
    ACCORD Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.CrossRefGoogle Scholar
  13. 13.
    Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ESH, Nissen SE, Kashyap SR. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med. 2014;370(21):2002–13.PubMedCrossRefGoogle Scholar
  14. 14.
    Ikramuddin S, Korner J, Lee WJ, Connett JE, Inabnet III WB, Billington CJ, Thomas AJ, Leslie DB, Chong K, Jeffery RW, Ahmed L, Vella A, Chuang LM, Bessler M, Sarr MG, Swain JM, Laqua P, Jensen MD, Bantle JP. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia. The diabetes surgery study randomized clinical trial. JAMA. 2013;309(21):2240–9.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Stone HB. Ann Surg. 1928;88(3):593–6.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Kral JG. Obesity surgery – state of the art. In: Van Itallie TB, Hirsch J, editors. Recent advances in obesity research IV. London: John Libbey; 1985. p. 237–46.Google Scholar
  17. 17.
    Smithy WB, Cuadros C, Johnson H, Kral JG. Effects of ileal interposition on body weight and intestinal morphology in dogs. Int J Obes. 1986;10:453–60.PubMedGoogle Scholar
  18. 18.
    Mason EE. Ileal [correction of ilial] transposition and enteroglucagon/GLP-1 in obesity (and diabetic?) surgery. Obes Surg. 1999;9:223–8.PubMedCrossRefGoogle Scholar
  19. 19.
    DePaula AL, Macedo ALV, Prudente A, Silva L, Schraibman V, GozaniNeto J, Pinus J, Cury EK, Szajnbok P, DiDario RP, Bertocco L, Diniz K, Gaudencio J, Bebin L, D’Orto U, Cison D, Penhavel F. Neuroendocrine brake for the treatment of morbid obesity. Preliminary report. Einstein. 2005;3(2):110–4.Google Scholar
  20. 20.
    De Paula AL, Macedo AL, Prudente AS, Queiroz L, Schraibman V, Pinus J. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”). Surg Obes Relat Dis. 2006;2:464–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Strader AD. Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav. 2006;88:277–82.PubMedCrossRefGoogle Scholar
  22. 22.
    Maljaars PW, Peters HP, Mela DJ, Masclee AA. Ileal brake: a sensible food target for appetite control. A review. Physiol Behav. 2008;95:271–81.PubMedCrossRefGoogle Scholar
  23. 23.
    DeFronzo RA, et al. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes Care. 2009;58(4):773–95.CrossRefGoogle Scholar
  24. 24.
    DePaula AL, Macedo LAV, Schraibman V, Mota BR, Vencio S. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20–34. Surg Endosc. 2009;23:1724–32.PubMedCrossRefGoogle Scholar
  25. 25.
    Cummings PC, Strader DS, Stanhope KI, Graham JI, Lee J, Raybould HE, Baskin DG, Havel PJ. Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the ucd-t2dm rat. Gastroenterology. 2010;138:2437–46.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Patriti A, Facchiano E, Annetti C, Aisa MD, Galli F, Fanneli C, Donini A. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005;15:1256–64.CrossRefGoogle Scholar
  27. 27.
    Patriti A, Alsa MC, Sidoni A, Galli N, Donini A. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-Kakizaki rats through an enhanced Proglucagon gene expression an L-cell number. Surgery. 2007;142:74–85.PubMedCrossRefGoogle Scholar
  28. 28.
    Boza C, Munoz R, Yung E, Mizone L, Gagner M. Sleeve gastrectomy with ileal transposition (SGIT) induces a significant weight loss and diabetes improvement without exclusion of the proximal intestine. J Gastrointest Surg. 2011;15:928–34.PubMedCrossRefGoogle Scholar
  29. 29.
    Zhang GY, Wang TT, Cheng ZQ, Feng JB, Hu SY. Resolution of diabetes mellitus by ileal interposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes. Can J Surg. 2011;54(4):243–51.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    DePaula A, Stival A, Halpern A, Vencio S. Thirty-day morbidity and mortality of the laparoscopic ileal interposition associated with sleeve gastrectomy for the treatment of type 2 diabetic patients with BMI <35: an analysis of 454 consecutive patients. World J Surg. 2011;35(1):102–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Celik A, Ugale S, Ofluoglu H, Asci M, Celik BO, Vural E, Aydin M. Technical feasibility and safety profile of laparoscopic diverted sleeve gastrectomy with ileal transposition (DSIT). Obes Surg. 2015;25:1184. doi: 10.1007/s11695-14-1518-1.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    DePaula AL, Stival AS, Macedo A, Ribamar J, Mancini M, Halpern A, Vencio S. Prospective randomized controlled trial comparing 2 versions of laparoscopic ileal interposition associated with sleeve gastrectomy for patients with type 2 diabetes with BMI 21–34 kg/m2. Surg Obes Relat Dis. 2010;6:296–305.CrossRefGoogle Scholar
  33. 33.
    DePaula AL, Stival AR, DePaula CCL, Halpern A, Vencio S. Surgical treatment of type 2 diabetes in patients with BMI below 35: mid-term outcomes of the laparoscopic ileal interposition associated with a sleeve gastrectomy in 202 consecutive cases. J Gastrointest Surg. 2012;16(5):967–76.PubMedCrossRefGoogle Scholar
  34. 34.
    Hari Kumar KVS, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, Modi KD. Ileal interposition with sleeve gastrectomy for control of type 2 diabetes. Diabetes Technol Ther. 2009;11:785–9.CrossRefGoogle Scholar
  35. 35.
    Tinoco A, El-Kadre L, Aquiar L, Tinoco R, Savassi-Rocha P. Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg. 2011;35:2238–44.PubMedCrossRefGoogle Scholar
  36. 36.
    Goel R, Amin P, Goel M, Marik S. Early remission of type 2 diabetes mellitus by laparoscopic ileal transposition with sleeve gastrectomy surgery in 23–35 BMI patients. Int J Diabetes Dev Ctries. 2011;31(2):91–6.CrossRefGoogle Scholar
  37. 37.
    Dolan K, Hatzifotis M, Newbury L. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesitiy. Obes Surg. 2004;14:165–9.PubMedCrossRefGoogle Scholar
  38. 38.
    DePaula AL, Halpern A, Muscelli E, Mari A, Stival A, Vencio V, Ferrannini E. Improvement in insulin sensitivity and b-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms. J Gastrointest Surg. 2011;15(8):1344–53.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Aureo L. DePaula
    • 1
  • Carolina C. L. DePaula
    • 1
  • Surendra Ugale
    • 1
  1. 1.Hospital de EspecialidadesSao PauloBrazil

Personalised recommendations